Southern African Journal of HIV Medicine

Papers
(The median citation count of Southern African Journal of HIV Medicine is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Weight gain in children from birth to 10 years on antiretroviral treatment18
A multidisciplinary approach for people with HIV failing antiretroviral therapy in South Africa17
Late-onset efavirenz toxicity: A descriptive study from Pretoria, South Africa17
Retrospective review of maternal HIV viral load electronic gatekeeping codes in South Africa16
The 96-week outcomes and pharmacokinetics of long-acting cabotegravir plus rilpivirine in South Africans13
Hepatitis B seroprevalence among HIV-positive adults in the Free State, South Africa12
Rural nurses’ antiretroviral prescribing practices in children, Limpopo province, South Africa12
Management of drug-induced liver injury in people with HIV treated for tuberculosis: 2024 update11
Confronting the human papillomavirus–HIV intersection: Cervical cytology implications for Kenyan women living with HIV11
Social support experiences of adolescents living with perinatal HIV in rural Limpopo, South Africa9
COVID-19 and HIV viral load suppression in children and adolescents in Durban, South Africa9
Doxycycline post-exposure prophylaxis for sexually transmitted infections in South Africa9
Cutaneous squamous cell carcinoma in vertically acquired HIV and epidermodysplasia verruciformis9
Cardiovascular risk profiles in people living with HIV taking antiretroviral therapy in rural Lesotho: Findings from the PRECARIF study9
Using creativity and the arts to promote mental health in youth living with HIV in South Africa8
Acknowledgement to reviewers8
Rifampicin resistance and mortality in patients hospitalised with HIV-associated tuberculosis8
The sexual and reproductive health needs of young people living with HIV in Gauteng, South Africa8
Effect of dolutegravir on ferritin, iron, and C-reactive protein among people living with HIV and co-infections7
Tracking viral control in adolescents on antiretroviral therapy in Lusaka, Zambia: A retrospective cohort analysis7
COVID-19 severity and in-hospital mortality in an area with high HIV prevalence7
High paediatric HIV viral load rejection rate in South Africa, a retrospective review6
Radiological predictors of PCP in HIV-positive adults in South Africa: A matched case-control study6
Interpersonal relations of pregnant women post-HIV diagnosis in Thembisile Hani, South Africa6
Effect of a ward-based outreach team and adherence game on retention and viral load suppression6
Identifying sexual behavioural choices when commencing pre-exposure prophylaxis: Findings from a public health facility in eThekwini, KwaZulu-Natal, South Africa6
Pharmacokinetics, pharmacogenetics, and toxicity of co-administered efavirenz and isoniazid6
Steatotic liver disease in people with HIV at Tshepong Hospital: A post-mortem analysis5
Acceptability and performance of dual HIV/syphilis testing in male circumcision clients, 20215
Table of Contents Vol 24, No 1 (2023)5
South African harm reduction guideline for chemsex5
HIV-associated Kaposi sarcoma: Advanced disease and high mortality of patients referred to a multidisciplinary clinic in South Africa, 2022–20245
The prevalence of multimorbidity in virally suppressed HIV-positive patients in Limpopo5
Corrigendum: Unlocking insights into HIV care: An in-depth analysis of key populations from the Fast-Track Cities Quality of Care survey in eThekwini, KwaZulu-Natal, South Africa5
Causes of death in adults living with HIV in South Africa: A single-centre postmortem study5
Transition of adolescents from paediatric to adult HIV care in South Africa: A policy review5
Southern African HIV Clinicians Society 2022 guideline for the management of sexually transmitted infections: Moving towards best practice4
Dolutegravir for second-line treatment: Programmatic implications of new evidence4
Thrombotic thrombocytopaenic purpura in the era of HIV: A single-centre experience4
A cross-sectional study of viral load suppression among youth living with HIV in Namibia4
HIV viral suppression after enhanced adherence counselling in children on dolutegravir-based regimens in Malawi4
Oral pre-exposure prophylaxis uptake, adherence, and adverse events among South African men who have sex with men and transgender women4
Stakeholders’ perspective on inclusion of key populations unique identifier codes in routine health information management system in South Africa4
Virologic outcomes with tenofovir-lamivudine-dolutegravir in adults failing PI-based second-line ART4
Table of Contents Vol 26, No 1 (2025)3
Longer-term virologic outcomes on tenofovir-lamivudine-dolutegravir in second-line ART3
Factors associated with viral suppression among adolescents on antiretroviral therapy in Free State province, South Africa3
Self-reported HIV testing and treatment among migrants from northeast South Africa: A cross-sectional, population-based analysis3
Table of Contents Vol 23, No 1 (2022)3
Rapid emergence of dolutegravir resistance on second-line dolutegravir-based ART3
No increased in utero and peripartum HIV acquisition risk in HIV-exposed preterm infants3
Dolutegravir resistance in three pregnant and breastfeeding women in South Africa3
COVID-19 vaccine acceptance and associated factors among people living with HIV in the Middle East and North Africa region3
Late-onset efavirenz toxicity: A descriptive study from Pretoria, South Africa3
Reflexed cryptococcal antigenaemia detection rates in the Western Cape, South Africa3
The prevalence of cervical abnormalities: Comparison of youth with perinatally acquired HIV and older women in Botswana3
Determinants of drop-offs in the targeted universal tuberculosis testing care cascade among people with HIV in rural and urban facilities in South Africa3
Causes of death in people living with HIV: Lessons from five health facilities in Eswatini3
Rapid development of drug resistance during initial dolutegravir-based antiretroviral therapy of an infant with HIV3
Incidence of hepatitis C virus infection among people living with HIV: An Egyptian cohort study3
Corrigendum: Diagnostic use of abdominal ultrasound in detecting extrapulmonary tuberculosis or lymphoma in an HIV-endemic region2
Using a mobile application for antiretroviral therapy adherence in people living with HIV: A longitudinal pilot study2
Tuberculosis preventive treatment uptake among patients initiating antiretroviral therapy in Malawi: Children left behind2
Emergent dolutegravir resistance in integrase-naïve, treatment experienced patients from Zimbabwe2
Retention in care of people on antiretroviral therapy who inject drugs in South Africa2
Table of Contents Vol 25, No 1 (2024)2
The rollout of paediatric dolutegravir and virological outcomes among children living with HIV in Mozambique2
Human rights violations among men who have sex with men and transgender people in South Africa2
Southern African HIV Clinicians Society guideline on pre-exposure prophylaxis to prevent HIV2
Breast carcinoma tumour-infiltrating lymphocytes in pre- and post-systemic therapy in HIV-positive and HIV-negative women2
HIV PrEP and PEP awareness and practices among emergency doctors in Gauteng province2
Association between antiretroviral therapy initiation or reinitiation timing and neuroimaging-confirmed stroke in people with HIV2
Beliefs affecting ART adherence in newly diagnosed HIV-positive participants in Manzini, Eswatini2
Adherence, perceptions and knowledge of an HIV PMTCT programme: A mother-baby pair study2
Outcomes of a model for re-testing HIV-negative index contacts in Sedibeng, South Africa1
Erratum: ‘Southern African HIV Clinicians Society gender-affirming healthcare guideline for South Africa’1
Healthcare services provided to pregnant women with HIV and their outcomes at primary healthcare clinics in the Free State province, South Africa1
Effect of HIV on mortality among hospitalised patients in South Africa1
Ethically acceptable consent approaches to adolescent research in South Africa1
Lived experience of people with cryptococcal meningitis: A qualitative study1
Segregated healthcare impact on patients living with HIV in a clinic in Botswana1
Viral suppression in adults on efavirenz- or dolutegravir-based antiretroviral therapy in Mopani District, South Africa1
Differentiated HIV service delivery model for female sex workers in sub-Saharan Africa: A systematic review1
Knowledge and attitudes in the prevention of vertical transmission of HIV in referral hospitals1
Barriers and facilitators of ongoing engagement in substance use treatment programmes among people with HIV in South Africa: A qualitative analysis1
Prevalence and incidence of physical and sexual intimate partner violence perpetration among adolescent boys living with and without HIV1
Condomless anal intercourse among HIV-positive and HIV-negative men who have sex with men in Zimbabwe1
Delivery models of HIV pre-exposure prophylaxis and their influence on uptake in South Africa: An integrative review1
Southern African HIV Clinicians Society 2023 Guideline for post-exposure prophylaxis: Updated recommendations1
Incidence and risk factors of anaemia among people on antiretroviral therapy in Harare1
Economic impact of extending reflexed cryptococcal antigenaemia CD4 threshold in South Africa1
Leveraging community pharmacies for HIV services in South Africa: Opportunities and constraints1
Assessing very advanced HIV disease in adolescent girls and young women1
HIV viral load suppression before and after COVID-19 in Kinshasa and Haut Katanga, Democratic Republic of the Congo1
Inflammatory mechanisms contributing to retinal alterations in HIV infection and long-term ART1
Reducing medication errors in HIV-positive patients: Influence of a clinical pharmacist1
Setting up a pharmacy HIV pre-exposure prophylaxis delivery model: Lessons and recommendations for implementation1
Diminished health and social outcomes among men who have sex with men who use drugs in Zimbabwe1
Outcomes and characteristics of patients on protease inhibitors at a tertiary level antiretroviral clinic1
0.052651166915894